PMC:7199903 / 13445-13620 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T49","span":{"begin":27,"end":35},"obj":"Disease"}],"attributes":[{"id":"A49","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T78","span":{"begin":81,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T79","span":{"begin":97,"end":99},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T80","span":{"begin":130,"end":132},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T135","span":{"begin":64,"end":71},"obj":"Chemical"},{"id":"T136","span":{"begin":165,"end":172},"obj":"Chemical"}],"attributes":[{"id":"A135","pred":"chebi_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"},{"id":"A136","pred":"chebi_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T62","span":{"begin":123,"end":128},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T94803","span":{"begin":8,"end":18},"obj":"NNS"},{"id":"T96472","span":{"begin":19,"end":26},"obj":"IN"},{"id":"T15388","span":{"begin":27,"end":37},"obj":"NN"},{"id":"T65870","span":{"begin":38,"end":39},"obj":"NN"},{"id":"T54929","span":{"begin":40,"end":43},"obj":"MD"},{"id":"T48495","span":{"begin":44,"end":51},"obj":"VB"},{"id":"T83428","span":{"begin":52,"end":63},"obj":"VBN"},{"id":"T33605","span":{"begin":64,"end":71},"obj":"NNS"},{"id":"T61395","span":{"begin":72,"end":74},"obj":"IN"},{"id":"T85817","span":{"begin":75,"end":79},"obj":"NN"},{"id":"T96270","span":{"begin":80,"end":81},"obj":"-LRB-"},{"id":"T72262","span":{"begin":81,"end":83},"obj":"CD"},{"id":"T73516","span":{"begin":83,"end":84},"obj":"-RRB-"},{"id":"T58385","span":{"begin":86,"end":92},"obj":"IN"},{"id":"T33257","span":{"begin":93,"end":96},"obj":"DT"},{"id":"T7279","span":{"begin":97,"end":99},"obj":"CD"},{"id":"T66085","span":{"begin":100,"end":108},"obj":"JJ"},{"id":"T50825","span":{"begin":109,"end":122},"obj":"NN"},{"id":"T5111","span":{"begin":123,"end":128},"obj":"NNS"},{"id":"T97279","span":{"begin":128,"end":129},"obj":"-COMMA-"},{"id":"T26983","span":{"begin":130,"end":132},"obj":"CD"},{"id":"T69394","span":{"begin":132,"end":133},"obj":"NN"},{"id":"T83730","span":{"begin":134,"end":137},"obj":"VBP"},{"id":"T54583","span":{"begin":138,"end":149},"obj":"VBN"},{"id":"T26054","span":{"begin":150,"end":153},"obj":"CC"},{"id":"T85194","span":{"begin":154,"end":156},"obj":"CD"},{"id":"T20514","span":{"begin":156,"end":157},"obj":"NN"},{"id":"T72708","span":{"begin":158,"end":160},"obj":"IN"},{"id":"T31556","span":{"begin":161,"end":164},"obj":"DT"},{"id":"T75023","span":{"begin":165,"end":172},"obj":"NNS"}],"relations":[{"id":"R48071","pred":"arg1Of","subj":"T94803","obj":"T96472"},{"id":"R50900","pred":"arg2Of","subj":"T65870","obj":"T96472"},{"id":"R11381","pred":"arg1Of","subj":"T65870","obj":"T15388"},{"id":"R33143","pred":"arg2Of","subj":"T48495","obj":"T54929"},{"id":"R13697","pred":"arg2Of","subj":"T33605","obj":"T48495"},{"id":"R22889","pred":"arg2Of","subj":"T33605","obj":"T83428"},{"id":"R87734","pred":"arg1Of","subj":"T48495","obj":"T61395"},{"id":"R83302","pred":"arg2Of","subj":"T85817","obj":"T61395"},{"id":"R89433","pred":"arg1Of","subj":"T85817","obj":"T96270"},{"id":"R12740","pred":"arg2Of","subj":"T72262","obj":"T96270"},{"id":"R17492","pred":"arg3Of","subj":"T73516","obj":"T96270"},{"id":"R29512","pred":"arg1Of","subj":"T26054","obj":"T58385"},{"id":"R16840","pred":"arg2Of","subj":"T5111","obj":"T58385"},{"id":"R72478","pred":"arg1Of","subj":"T5111","obj":"T33257"},{"id":"R71033","pred":"arg1Of","subj":"T5111","obj":"T7279"},{"id":"R63820","pred":"arg1Of","subj":"T5111","obj":"T66085"},{"id":"R36388","pred":"arg1Of","subj":"T5111","obj":"T50825"},{"id":"R30804","pred":"arg1Of","subj":"T26054","obj":"T97279"},{"id":"R5539","pred":"arg1Of","subj":"T69394","obj":"T26983"},{"id":"R45010","pred":"arg1Of","subj":"T69394","obj":"T83730"},{"id":"R44415","pred":"arg2Of","subj":"T54583","obj":"T83730"},{"id":"R14603","pred":"arg2Of","subj":"T69394","obj":"T54583"},{"id":"R44577","pred":"arg1Of","subj":"T54583","obj":"T26054"},{"id":"R71419","pred":"arg1Of","subj":"T20514","obj":"T85194"},{"id":"R84178","pred":"arg1Of","subj":"T20514","obj":"T72708"},{"id":"R52453","pred":"arg2Of","subj":"T75023","obj":"T72708"},{"id":"R31250","pred":"arg1Of","subj":"T75023","obj":"T31556"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T103","span":{"begin":64,"end":71},"obj":"Chemical"},{"id":"T104","span":{"begin":165,"end":172},"obj":"Chemical"}],"attributes":[{"id":"A103","pred":"chebi_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"},{"id":"A104","pred":"chebi_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T53","span":{"begin":27,"end":37},"obj":"Species"}],"attributes":[{"id":"A53","pred":"ncbi_taxonomy_id","subj":"T53","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T43","span":{"begin":27,"end":37},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"454","span":{"begin":38,"end":39},"obj":"Gene"},{"id":"455","span":{"begin":27,"end":37},"obj":"Species"},{"id":"457","span":{"begin":64,"end":71},"obj":"Chemical"},{"id":"458","span":{"begin":100,"end":101},"obj":"Chemical"},{"id":"459","span":{"begin":165,"end":172},"obj":"Chemical"}],"attributes":[{"id":"A454","pred":"pubann:denotes","subj":"454","obj":"Gene:43740568"},{"id":"A455","pred":"pubann:denotes","subj":"455","obj":"Tax:2697049"},{"id":"A457","pred":"pubann:denotes","subj":"457","obj":"MESH:D011134"},{"id":"A458","pred":"pubann:denotes","subj":"458","obj":"MESH:D009584"},{"id":"A459","pred":"pubann:denotes","subj":"459","obj":"MESH:D011134"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T35","span":{"begin":109,"end":122},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T33","span":{"begin":109,"end":122},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T38","span":{"begin":100,"end":122},"obj":"http://purl.obolibrary.org/obo/GO_0006487"},{"id":"T39","span":{"begin":109,"end":122},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}

{"project":"LitCovid-PubTator","denotations":[{"id":"454","span":{"begin":38,"end":39},"obj":"Gene"},{"id":"455","span":{"begin":27,"end":37},"obj":"Species"},{"id":"457","span":{"begin":64,"end":71},"obj":"Chemical"},{"id":"458","span":{"begin":100,"end":101},"obj":"Chemical"},{"id":"459","span":{"begin":165,"end":172},"obj":"Chemical"}],"attributes":[{"id":"A454","pred":"tao:has_database_id","subj":"454","obj":"Gene:43740568"},{"id":"A455","pred":"tao:has_database_id","subj":"455","obj":"Tax:2697049"},{"id":"A457","pred":"tao:has_database_id","subj":"457","obj":"MESH:D011134"},{"id":"A458","pred":"tao:has_database_id","subj":"458","obj":"MESH:D009584"},{"id":"A459","pred":"tao:has_database_id","subj":"459","obj":"MESH:D011134"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"alizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans co"}